https://www.zacks.com/stock/news/2237551/here-s-why-you-should-retain-walgreens-boots-wba-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2237551
Mar 07, 2024 - Investors are optimistic about Walgreens Boots (WBA), led by its strategic partnerships and long-term growth model.
zc:-4688381384700326572
0
https://www.zacks.com/stock/news/2237550/abbott-abt-to-reduce-childhood-malnutrition-with-new-pact?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2237550
Mar 07, 2024 - Abbott's (ABT) latest partnership supports its sustainability goal of transforming care for malnutrition and improving the lives of 3 billion people per year by the decade's end.
zc:1815782283625796570
0
https://www.zacks.com/stock/news/2237419/phibro-pahc-appears-well-poised-on-launches-vaccine-sales?cid=CS-ZC-FT-analyst_blog|zer_report_update-2237419
Mar 07, 2024 - Phibro (PAHC) is focusing on new developments along with incremental registrations and growing volumes of existing nutritional specialties and vaccine technologies.
zc:-7444438580819497867
0
https://www.zacks.com/stock/news/2236222/reasons-to-retain-prestige-consumer-pbh-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2236222
Mar 05, 2024 - Investors are optimistic about Prestige Consumer (PBH) on increasing gain in market share for its wide array of brands.
zc:8602494584614886584
0
https://www.zacks.com/stock/news/2236218/cvs-health-cvs-expands-in-home-diagnostic-care-with-new-test?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2236218
Mar 05, 2024 - CVS Health's (CVS) new launch will enable early detection of heart arrhythmia and can help mitigate symptoms and more severe complications.
zc:1065628131519793942
0
https://www.zacks.com/stock/news/2234635/myriad-genetics-mygn-to-evaluate-mrd-testing-with-new-pact?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2234635
Mar 01, 2024 - Myriad Genetics' (MYGN) MRD test is uniquely capable of detecting ctDNA at the lowest levels of detection, which is essential for a pan-cancer investigation.
zc:-110463571899944335
0
https://www.zacks.com/stock/news/2232656/here-s-why-investors-should-retain-steris-ste-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2232656
Feb 27, 2024 - Investors are optimistic about STERIS (STE) on continuous recovery of healthcare procedures and upbeat 2024 guidance.
zc:-6136510649045583319
0
https://www.zacks.com/stock/news/2232652/quest-diagnostics-dgx-new-pact-to-reduce-food-insecurity?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2232652
Feb 27, 2024 - Quest Diagnostics' (DGX) recent collaboration aims to advance food access and healthy eating habits for underserved communities.
zc:-810626733911373088
0
https://www.zacks.com/stock/news/2232605/hae-or-syk-which-is-the-better-value-stock-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2232605
Feb 27, 2024 - HAE vs. SYK: Which Stock Is the Better Value Option?
zc:1212885221901401874
0
https://www.zacks.com/stock/news/2231893/here-s-why-you-should-buy-edward-lifesciences-ew-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2231893
Feb 26, 2024 - Investors are optimistic about Edward Lifesciences' (EW) progress with the Structural Heart business and strong TAVR potential.
zc:-2662122675367703698
0